Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. France
  4. Euronext Paris
  5. NEOVACS
  6. Summary
    ALNEV   FR0004032746

NEOVACS

(ALNEV)
  Report
 SummaryQuotesChartsNewsCalendarCompanyFinancials 
Quotes 5-day view   Real-time Quote. Real-time Euronext Paris
07/26/2021 07/27/2021 07/28/2021 07/29/2021 07/30/2021 Date
0.0037(c) 0.0039(c) 0.0038(c) 0.0036(c) 0.0035 Last
47 571 961 51 099 479 71 641 039 114 229 388 110 321 508 Volume
+2.78% +5.41% -2.56% -5.26% -2.78% Change
More quotes
Estimated financial data (e)
Sales 2019 0,10 M 0,11 M 0,11 M
Net income 2019 -7,55 M -8,97 M -8,97 M
Net cash position 2019 1,23 M 1,47 M 1,47 M
P/E ratio 2019 -1,21x
Yield 2019 -
Sales 2020 0,03 M 0,04 M 0,04 M
Net income 2020 -6,14 M -7,30 M -7,30 M
Net cash position 2020 9,68 M 11,5 M 11,5 M
P/E ratio 2020 -3,31x
Yield 2020 -
Capitalization 12,8 M 15,2 M 15,2 M
EV / Sales 2019 74,3x
EV / Sales 2020 -137x
Nbr of Employees 15
Free-Float 99,6%
More Financials
Company
Neovacs SA is a France-based company active in the biotechnology industry. It specializes in immunotherapy domain and providing treatment for autoimmune and inflammatory diseases. The Company researches and develops Kinoids, drug-candidates which aim to treat disease by including an antibody response in the patient. The Company focuses its development effort on two Kinoids for Crohn’s disease, Rheumatoid Arthritis... 
More about the company
All news about NEOVACS
07/07GLOBAL MARKETS LIVE : Wise, Amazon, Microsoft, Nintendo, Nikola....
07/05GLOBAL MARKETS LIVE : WM Morrison, IBM, Didi...
06/29Neovacs S.A. Reports Earnings Results for the Full Year Ended December 31, 20..
CI
06/22GLOBAL MARKETS LIVE : Netflix, Boeing, Tesla, Delta Air Lines, Blackstone Resour..
06/21Neovacs S.A. announced that it has received €4 million in funding
CI
06/08Neovacs S.A. announced that it expects to receive €2 million in funding from ..
CI
05/17GLOBAL MARKETS LIVE : AT&T, GSK, Discovery, Microsoft, Tesla...
2020Neovacs S.A. Reports Earnings Results for the Half Year Ended June 30, 2020
CI
2020NEOVACS : Monthly statement on outstanding equity shares and voting rights
CO
2020NEOVACS : Tableau de suivi des VM donnant accès au capital (OCEANEs) au 11/08/20..
PU
2020Neovacs Plans to Take over Famar Lyon
CI
2020NEOVACS : Neovacs shares to resume trading on may 20th, 2020
AN
2020NEOVACS : Validation of the "restarted" plan by the paris commercial court
AN
2020Neovacs S.A. announced that it expects to receive €40 million in funding from..
CI
2020NEOVACS : DRAFT CONTINUITY PLAN // REVIEW HEARING SCHEDULED FOR MAY 6th, 2020
AN
More news
News in other languages on NEOVACS
07/29NEOVACS : Levée de fonds de 2 meur
07/29NEOVACS : Levée de fonds de 2 meur
07/23FINANCEMENTS DILUTIFS : la machine à Penny Stocks
07/08NEOVACS : Assemblée générale 2021
07/07NÉOVACS : le titre rebondit après un article dans 'Allergy'
More news
Chart NEOVACS
Duration : Period :
NEOVACS Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends NEOVACS
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Managers and Directors
Vincent Serra Chief Executive Officer
Baptiste Pourtout Chief Financial Officer
Thérèse Croughs Chief Medical Officer
Patrick Valroff Independent Director
Daniel Zagury Director
Sector and Competitors
1st jan.Capi. (M$)
NEOVACS-88.08%15
MODERNA, INC.230.85%138 784
LONZA GROUP AG21.77%56 806
IQVIA HOLDINGS INC.38.81%47 656
CELLTRION, INC.-27.16%31 282
SEAGEN INC.-16.10%26 668